[Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
D000493:Allopurinol / Q000627:therapeutic use*; D001553:Benzbromarone / Q000627:therapeutic use*; D001572:Benzofurans / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005235:Fatty Liver, Alcoholic / Q000097:blood / Q000188:drug therapy*; D006073:Gout / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D019271:Hypoxanthine; D007042:Hypoxanthines / Q000097:blood; D014527:Uric Acid / Q000097:blood*; D019820:Xanthine; D014970:Xanthines / Q000097:blood
D001572:Benzofurans; D007042:Hypoxanthines; D014970:Xanthines; D019820:Xanthine; D014527:Uric Acid; D019271:Hypoxanthine; D001553:Benzbromarone; D000493:Allopurinol
Aktuelle Therapie: Kombinierte medikamentöse Therapie von Hyperurikämie, Gicht und Alkohol-induzierter Fettleber.